SouthState Bank Corp. · SSB · FY2026 Q2 · Calendar Q3 2026
SouthState reports stronger loan growth and stable NIM
The quarter supports a constructive but qualified view: stronger loan growth, stable NIM, improved credit quality and productivity initiatives provide evidence of operating momentum, while funding costs, credit exposure and expense discipline remain tests for sustained growth.
Earnings scorecard
Reported versus consensusMarket reaction
event-close to next-session closeAsk FN2 about SSB FY2026 Q2
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior quarter, loan growth accelerated, credit metrics improved and management described broader AI deployment. The company also emphasized a larger floating-rate mix and continued capital returns, while keeping guidance unchanged.
Guidance delta
Management's guidance remained unchanged, with stable NIM and deposit-growth expectations for the remainder of 2026.
Key takeaways
- Loan growth accelerated, supported by commercial-banking expansion and new hires.
- Credit quality improved, with non-performing assets down and net charge-offs remaining low.
- Management highlighted AI-enabled productivity gains and continued capital returns.
Management priorities
- Expand the commercial-banking sales force and deepen coverage in existing markets.
- Continue integrating AI tools across credit, fraud management and customer service.
- Maintain mid- to high-single-digit loan growth and a 40%-60% total payout ratio.
Follow SSB with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 23, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Truist Securities | Buy | Buy | Maintain | Oct 9, 2026 |
| TD Cowen | Buy | Buy | Maintain | Oct 5, 2026 |
| Barclays | Overweight | Overweight | Maintain | Oct 5, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Oct 1, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 28, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Jul 27, 2026 |
| DA Davidson | Buy | Buy | Maintain | Jun 10, 2026 |
| Jefferies | Buy | Buy | Maintain | Feb 2, 2026 |
| Stephens & Co. | Overweight | Overweight | Maintain | Jan 26, 2026 |
| Raymond James | Strong Buy | Strong Buy | Maintain | Jan 7, 2026 |
| UBS | Buy | Buy | Maintain | Nov 5, 2025 |
| Keefe, Bruyette & Woods | Outperform | Outperform | Maintain | May 6, 2025 |
| Hovde Group | Market Perform | Outperform | Downgrade | Nov 13, 2024 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | May 5, 2020 |
| Keefe Bruyette & Woods | Market Perform | Outperform | Downgrade | Apr 25, 2018 |
| FIG Partners | Outperform | Outperform | Maintain | Jan 25, 2016 |
| PiperJaffray | Neutral | Neutral | Maintain | Sep 21, 2015 |
| Wunderlich Securities | Hold | Buy | Downgrade | Jun 22, 2015 |
| Wunderlich | Hold | Buy | Downgrade | Jun 22, 2015 |
| Sandler O'Neill | Hold | Buy | Downgrade | Jan 27, 2015 |
Named analyst price targets
Upside is calculated against the persisted current price $105.22. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Truist Financial | Analyst unavailable | $113 | $100.57 | +7.4% | Oct 9, 2026 |
| Barclays | Analyst unavailable | $120 | $101.91 | +14.0% | Oct 5, 2026 |
| Truist Financial | Analyst unavailable | $118 | $105.68 | +12.1% | Jul 28, 2026 |
| Stephens | Analyst unavailable | $116 | $105.9 | +10.2% | Jul 27, 2026 |
| Piper Sandler | Stephen Scouten | $125 | $106 | +18.8% | Jul 27, 2026 |
| Piper Sandler | Stephen Scouten | $120 | $104.4 | +14.0% | Jul 24, 2026 |
| Barclays | Analyst unavailable | $118 | $100.28 | +12.1% | Jul 7, 2026 |
| UBS | Analyst unavailable | $108 | $100.84 | +2.6% | Jul 7, 2026 |
| Fundamental Research | Analyst unavailable | $120 | $99.9 | +14.0% | Jul 1, 2026 |
| Truist Financial | John McDonald | $108 | $94.86 | +2.6% | Apr 27, 2026 |
| Barclays | Analyst unavailable | $123 | $94.86 | +16.9% | Apr 27, 2026 |
| Truist Financial | Analyst unavailable | $110 | $91.96 | +4.5% | Mar 26, 2026 |
| UBS | Analyst unavailable | $121 | $105.56 | +15.0% | Feb 4, 2026 |
| Stephens | Russell Gunther | $120 | $99.86 | +14.0% | Jan 26, 2026 |
| D.A. Davidson | Analyst unavailable | $119 | $99.8 | +13.1% | Jan 26, 2026 |
| Barclays | Analyst unavailable | $126 | $100.19 | +19.7% | Jan 26, 2026 |
| Barclays | Analyst unavailable | $122 | $97.33 | +15.9% | Dec 19, 2025 |
| Barclays | Analyst unavailable | $125 | $88.86 | +18.8% | Nov 11, 2025 |
| UBS | Nicholas Holowko | $120 | $87.91 | +14.0% | Nov 5, 2025 |
| Stephens | Analyst unavailable | $110 | $90.47 | +4.5% | Oct 27, 2025 |
| Piper Sandler | Analyst unavailable | $118 | $90.47 | +12.1% | Oct 27, 2025 |
| D.A. Davidson | Gary Tenner | $117 | $90.38 | +11.2% | Oct 23, 2025 |
| Barclays | Analyst unavailable | $128 | $100.01 | +21.6% | Oct 8, 2025 |
| Raymond James | Analyst unavailable | $120 | $100.76 | +14.0% | Oct 7, 2025 |
| National Bank | Analyst unavailable | $127 | $100.24 | +20.7% | Sep 24, 2025 |
| Raymond James | Analyst unavailable | $110 | $87.49 | +4.5% | Apr 28, 2025 |
| Raymond James | Strong Buy | $115 | $94.67 | +9.3% | Apr 2, 2025 |
| Stephens | Russell Gunther | $105 | $98.47 | -0.2% | Oct 29, 2024 |
| Truist Financial | Brandon King | $103 | $98.06 | -2.1% | Oct 28, 2024 |
| Truist Financial | Brandon King | $109 | $100.18 | +3.6% | Jul 29, 2024 |
| Stephens | Russell Gunther | $101 | $100.18 | -4.0% | Jul 29, 2024 |
| D.A. Davidson | Gary Tenner | $112 | $98.88 | +6.4% | Jul 26, 2024 |
| Piper Sandler | Stephen Scouten | $98 | $75.57 | -6.9% | May 29, 2024 |
| Raymond James | Michael Rose | $90 | $79.87 | -14.5% | May 21, 2024 |
| Piper Sandler | Stephen Scouten | $95 | $77.7 | -9.7% | Apr 29, 2024 |
| Piper Sandler | Stephen Scouten | $96 | $77.63 | -8.8% | Sep 28, 2022 |
| Truist Financial | Jennifer Demba | $90 | $75.6 | -14.5% | Jun 15, 2022 |
Track every rating change on SSB the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationSouthState Bank Corporation operates as the bank holding company for SouthState Bank, National Association that provides a range of banking services and products to individuals and companies in the United States. The company offers checking accounts, savings accounts, money market accounts, and time deposit accounts; interest-bearing deposits, certificates of deposits, and other time deposits; and interest-bearing transaction accounts. It provides bond accounting services for correspondents, asset/liability consulting related activities, international wires, and other clearing and corporate checking account services.…
Historical context
All SSB earningsFinancial Services peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| NDAQ Nasdaq, Inc. | FY2026 Q3 · Calendar Q4 2026 | +2.0% | +7.5% | Nasdaq Q3: AI, cloud and market infrastructure sustain growth |
| BCS Barclays PLC | FY2026 Q3 · Calendar Q4 2026 | -1.5% | -2.6% | Barclays balances growth and efficiency with outlook maintained |
| PNFP Pinnacle Financial Partners, Inc. | FY2026 Q3 · Calendar Q4 2026 | +2.7% | +2.3% | PNFP: Strong loan growth and fee income, guidance maintained |
| BPOP Popular, Inc. | FY2026 Q3 · Calendar Q4 2026 | — | -2.8% | Popular’s Q3 growth remained solid as public deposits declined |
| BX Blackstone Inc. | FY2026 Q3 · Calendar Q4 2026 | — | +8.4% | Blackstone highlights AI infrastructure and fundraising momentum |
| HBANM Huntington Bancshares Incorporated | FY2026 Q3 · Calendar Q4 2026 | — | +0.5% | Huntington maintains 2027 outlook as fee growth offsets pressure |
Latest beats and misses
Who reports nextBeat on EPS
- NDAQFY2026 Q3 · October 22, 2026+2.0% EPS+7.5% move
- DOWFY2026 Q3 · October 22, 2026+11.3% EPS+4.7% move
- ALLEFY2026 Q3 · October 22, 2026+4.0% EPS+11.0% move
- CBREFY2026 Q3 · October 22, 2026+4.6% EPS-2.5% move
- RFY2026 Q3 · October 22, 2026+4.3% EPS+10.5% move
- WDCFY2027 Q1 · October 22, 2026+12.9% EPS-6.4% move
Missed on EPS
Get the SSB recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-07-24T17:04:46.996612+00:00
- FN2 earnings calendar · 2026-08-27T01:23:13.912278+00:00
- Polygon adjusted daily market bars · 2026-10-23T02:20:38.555982+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-23T02:20:38.553215+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-23. For educational purposes only; not investment advice.